Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Ospedale Santa Croce-Carle Cuneo220 enrolled

Overview

Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan in asymptomatic patients.

Study Type

OBSERVATIONAL

Enrollment

220

Conditions

Hematological Diseases Invasive Aspergillosis

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 16 years * Allogeneic HSCT for a haematological disease * Written informed consent to the study Exclusion Criteria: * Pediatric patients

Locations (1)

Azienda Sanitaria Ospedaliera santa Croce e Carle

Cuneo, Italy

Outcomes

Primary Outcomes

Incidence of invasive aspergillosis

Time frame: 1 year

Secondary Outcomes

Clinical applicability of the EORTC/MSG criteria in a prospective multicenter trial

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.